T-Darpp Activates IGF-1R Signaling to Regulate Glucose Metabolism in Trastuzumab-Resistant Breast Cancer Cells

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-17-0824
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Expression of T-Darpp Mediates Trastuzumab Resistance in Breast Cancer Cells

Clinical Cancer Research
Cancer ResearchOncology
2008English

Overcoming Trastuzumab Resistance in Breast Cancer by Targeting Dysregulated Glucose Metabolism

Cancer Research
Cancer ResearchOncology
2011English

Anti-Igf-1r Monoclonal Antibody Inhibits the Carcinogenicity Activity of Acquired Trastuzumab-Resistant SKOV3

Journal of Ovarian Research
GynecologyOncologyObstetrics
2014English

Revisiting the IGF-1R as a Breast Cancer Target

npj Precision Oncology
2017English

ALK and IGF-1R as Independent Targets in Crizotinib Resistant Lung Cancer

Scientific Reports
Multidisciplinary
2017English

Molecular Imaging of IGF-1R in Cancer

Molecular Imaging
Nuclear MedicineRadiologyMolecular MedicineCondensed Matter PhysicsImagingBiotechnologyBiomedical Engineering
2017English

Figure 1: IGF-1R and EGFR Signaling Pathway.

English

Mechanisms of Acquired Resistance to Trastuzumab Emtansine in Breast Cancer Cells

Molecular Cancer Therapeutics
Cancer ResearchOncology
2018English

Trastuzumab-Resistant Breast Cancer Cells Remain Sensitive to the Auger Electron-Emitting Radiotherapeutic Agent 111In-NLS-Trastuzumab and Are Radiosensitized by Methotrexate

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy